HISTOGENICS CORP (67) | Purchase Agreements (9)

Recent Contracts

Form of Securities Purchase Agreement (Filed With SEC on April 27, 2021)
Form of Securities Purchase Agreement (Filed With SEC on February 9, 2021)
Amendment No. 2 to Asset Purchase Agreement, dated October 4, 2019, by and between the Company and Medavate Corp (Filed With SEC on October 7, 2019)
Amendment No. 1 to Asset Purchase Agreement, dated September 26, 2019, by and between the Company and Medavate Corp (Filed With SEC on October 1, 2019)
Form of Amendment to Securities Purchase Agreement, dated as of June 28, 2019, by and among Histogenics Corporation, Ocugen, Inc. and the investor named therein (Filed With SEC on July 3, 2019)
Securities Purchase Agreement, dated as of June 13, 2019, by and among Histogenics Corporation, Ocugen, Inc. and certain investors named therein (Filed With SEC on June 14, 2019)
Securities Purchase Agreement, dated as of May 21, 2019, by and among Ocugen, Inc. and the investors party thereto (Filed With SEC on June 14, 2019)
Security Agreement, dated as of May 21, 2019, by Ocugen, Inc. in favor of HB Fund LLC, in its capacity as collateral agent for the investors party to the Securities Purchase... (Filed With SEC on June 14, 2019)
Asset Purchase Agreement dated May 8, 2019 by and between Histogenics Corporation and Medavate Corp (Filed With SEC on May 13, 2019)